Our results demonstrated that the CXCL14/CCR7/STAT3 axis significantly promotes the glycolytic shift in bladder cancer cells by upregulating the expression of HK2 and LDHA, two key glycolytic enzymes. The gene discussed is STAT3; the disease is urinary bladder cancer.